Peer review reports
From: Effect of alirocumab on cataracts in patients with acute coronary syndromes
Original Submission | ||
---|---|---|
25 Aug 2022 | Submitted | Original manuscript |
Resubmission - Version 2 | ||
Submitted | Manuscript version 2 | |
Resubmission - Version 3 | ||
Submitted | Manuscript version 3 | |
27 Feb 2023 | Reviewed | Reviewer Report - Dov Gavish |
22 Mar 2023 | Reviewed | Reviewer Report - Aref Rahman |
17 Apr 2023 | Author responded | Author comments - Ph. Gabriel Steg |
Resubmission - Version 4 | ||
17 Apr 2023 | Submitted | Manuscript version 4 |
18 Apr 2023 | Author responded | Author comments - Ph. Gabriel Steg |
Resubmission - Version 5 | ||
18 Apr 2023 | Submitted | Manuscript version 5 |
25 Apr 2023 | Author responded | Author comments - Ph. Gabriel Steg |
Resubmission - Version 6 | ||
25 Apr 2023 | Submitted | Manuscript version 6 |
1 May 2023 | Author responded | Author comments - Ph. Gabriel Steg |
Resubmission - Version 7 | ||
1 May 2023 | Submitted | Manuscript version 7 |
4 May 2023 | Reviewed | Reviewer Report - Aref Rahman |
Resubmission - Version 8 | ||
Submitted | Manuscript version 8 | |
Publishing | ||
2 Jun 2023 | Editorially accepted | |
16 Jun 2023 | Article published | 10.1186/s12886-023-03012-1 |